These data are claimed to support the use of LIXIANA as an effective and safe alternative to the best possible conventional treatment with enoxaparin
They were randomly assigned to receive one daily subcutaneous injection of 40 mg enoxaparin
or placebo until 35 weeks' gestation.
This article will address three LMWHs: enoxaparin
, dalteparin, and tinzaparin.
Methods: In this prospective observational study 150 women with a history of two or more previous unexplained first trimester pregnancy loss who received LMWH; either enoxaparin
(n=50) tinzaparin (n=50) or nothing (n=50) were followed for the pregnancy outcome measures.
PATIENT'S CLAIM The hemorrhage was caused when enoxaparin
was given at 1.
The present in vitro experiments were planned to determine whether the DTIs lepirudin and argatroban and the predominantly factor Xa inhibitors enoxaparin
, danaparoid, and fondaparinux could interfere with the result of LA testing based on dPT.
The follow-up analysis of three recently completed international clinical studies on short-term venous thromboembolism (VTE) protective medicine in patients undergoing major orthopedic surgery demonstrated that the ultra-low-molecular-weight heparin semuloparin reduced the incidence of VTE and all-cause death by 25 per cent compared to the commonly used therapy drug enoxaparin
(a low-molecular-weight heparin).
After a cardiac consultation, she was started on 3 anticoagulants, including enoxaparin
NEW ORLEANS -- The investigational oral anticoagulant rivaroxaban was as effective as injection enoxaparin
in preventing venous thromboembolism at 10 days and superior at 35 days among critically ill hospitalized patients in the phase III MAGELLAN study.
After stopping warfarin, shots of enoxaparin
are given twice daily under the skin.
Before approving generic enoxaparin
sodium injection, we expected, among other things, a series of sophisticated analytical tests and a study in healthy volunteers to assure that the drug would be as safe and effective as the brand name product," explains Keith Webber, deputy director of the FDA's office of pharmaceutical science.
The US Food and Drug Administration (FDA) has granted approval of the first generic formulation of enoxaparin
(Lovenox, Sanofi-Aventis) sodium injection, a low-molecular-weight heparin used for multiple indications, including the treatment of acute ST-segment-elevation MI and the prevention of ischemic complications from unstable angina and non-Q-wave MI 1 .